Ionian University
Integrated approach of involved computational biomarkers towards designing personalized precision medicine protocols for amyotrophic lateral sclerosis
Abstract
dc:descriptionAmyotrophic lateral sclerosis (ALS) presents a formidable challenge due to its devastating impact and the complexity of its etiology. This comprehensive study delves into the multifaceted nature of ALS, employing a holistic approach that integrates genetic analysis, biomarker discovery, omics technologies, and drug repurposing strategies. By focusing on the genetic landscape of ALS, this research identified crucial variations and mutations in pivotal genes such as SOD1, C9ORF72, TARDBP, and FUS, highlighting the disease's genetic heterogeneity and the necessity for personalized medicine. Biomarker exploration unveiled potential candidates for early diagnosis and monitoring disease progression, emphasizing neurofilaments, inflammatory mediators, and specific miRNAs. Leveraging proteomics and metabolomics, this research unveiled novel insights into molecular alterations associated with ALS, pointing towards innovative therapeutic targets. A significant portion of this study was dedicated to drug repurposing, utilizing machine learning, cheminformatics, and network-based analyses to identify FDA-approved drugs with potential efficacy against ALS, particularly targeting the TDP-43 protein implicated in a majority of cases. This endeavor resulted in the identification of several promising therapeutic agents, offering a quicker path to clinical application. The construction of a drug-target network (DTN) and subsequent functional enrichment analysis provided a deeper understanding of the intricate molecular interplay in ALS and highlighted the complexity of its pathology. This study's findings contribute significantly to our understanding of ALS, offering new perspectives on its genetic and biomolecular mechanisms and presenting a foundation for future therapeutic strategies. By identifying promising drug candidates and elucidating the molecular pathways involved in ALS, this research paves the way for further experimental validation and clinical trials, aiming to transform these insights into effective treatments for ALS.
Degree
thesis:*- Grantor dc:publisher
- Ionian University
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kadena, Katerina
- Καδένα, Κατερίνα
Subjects
dc:subject × 22- Πλάγια αμυοτροφική σκλήρυνση
- Βιοδείκτες
- Μηχανική μάθηση
- Eπαναχρησιμοποίηση φαρμάκων
- Δίκτυο στόχων φαρμάκων
- Γενετικές παραλλαγές
- Τεχνολογίες Omics
- Εξατομικευμένη ιατρική
- Amyotrophic lateral sclerosis
- Biomarkers
- Drug repurposing
- Machine learning
- Drug target network
- Genetic variations
- Omics technologies
- Personalized medicine
- Επιστήμη Ηλεκτρονικών Υπολογιστών και Πληροφορική
- Φυσικές Επιστήμες
- Βιοπληροφορική
- Computer and Information Sciences
- Natural Sciences
- Bioinformatics
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/57554